The tumor suppressor protein p53 plays an important role in maintenance of the genomic integrity of cells. p53 possesses an intrinsic 3 0 -5 0 exonuclease activity. p53 was found in the nucleus and in the cytoplasm of the cell. In order to evaluate the subcellular location and extent of p53-associated 3 0 -5 0 exonuclease activity, we established an in vitro experimental system of cell lines with different nuclear/cytoplasmic distribution of p53. Nuclear and cytoplasmic extracts obtained from LCC2 cells (expressing a high level of cytoplasmic wild-type p53), MCF-7 cells (expressing a high level of wild-type nuclear p53), MDA cells (expressing mutant p53) and H1299 cells (p53-null) were subjected to the analysis of exonuclease activity. Interestingly, 3 0 -5 0 exonuclease was predominantly cytoplasmic; the nuclear extracts derived from all cell lines tested, exerted a low level of exonuclease activity. Cytoplasmic extracts of LCC2 cells, with a high level of wild-type p53, showed an enhanced exonuclease activity in comparison to those expressing either a low level of wild-type p53 (in MCF-7 cells) or the mutant p53 (in MDA cells). Evidence that exonuclease function detected in cytoplasmic extracts is attributed to the p53 is supported by several facts: First, this activity closely parallels with levels and status of endogenous cytoplasmic p53. Second, immunoprecipitation of p53 from cytoplasmic extracts of LCC2 cells markedly reduced the exonuclease activity. Third, the observed 3 0 -5 0 exonuclease in cytoplasmic fraction of LCC2 cells displays identical biochemical properties characteristic of recombinant wild-type p53. The biochemical functions include: (a) substrate specificity; exonuclease hydrolyzes singlestranded DNA in preference to double-stranded DNA and RNA/DNA template-primers, (b) efficient excision of 3 0 -terminal mispairs from DNA/DNA and RNA/DNA substrates, (c) the preferential excision of purine-purine mispairs over purine-pyrimidine mispairs and (d) functional interaction with exonuclease-deficient DNA polymerase, for example, murine leukemia virus reverse transcriptase (representing a relatively low fidelity enzyme), thus enhancing the fidelity of DNA synthesis by excision of mismatched nucleotides from the nascent DNA strand. Taken together, the data demonstrate that wildtype p53 in cytoplasm, in its noninduced state, is functional; it displays intrinsic 3 0 -5 0 exonuclease activity. The possible role of p53-associated 3 0 -5 0 exonuclease activity in DNA repair in nucleus and cytoplasm is discussed.
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Introduction
The tumor suppressor protein p53, a potent mediator of cellular responses to DNA damage, is biochemically involved in the induction of cell-cycle arrest, apoptosis or DNA repair, all of which contribute to maintenance of genetic stability in mammalian cells Prives and Hall, 1999) . Under normal conditions of cell growth, p53 exists at low levels in a latent state (Soussi, 1995) . However, various intracellular and extracellular signals, including ionizing radiation (Kastan et al., 1991) , UV radiation (Nelson and Kastan, 1994) , hypoxia (Graeber et al., 1994) or nucleotide deprivation (Linke et al., 1996) , can induce the formation of activated p53. The high levels of functional p53 correlate with arrest at the G1 phase of the cell cycle, allowing DNA repair prior to cell division or elimination of cells with extensive DNA damage by apoptosis (Cox et al., 1995) . p53 is a multifunctional protein with multiple modifications and biochemical properties. The cellular response to DNA damage presumably involves the capacity of p53 to bind to specific DNA sequences and to function as a transcription factor, which both transactivates and transrepresses specific genes involved in controlling cell cycle and apoptosis (Prives and Hall, 1999) . The transactivationindependent functions of p53 include DNA repair through nonsequence-specific DNA binding. Indeed, p53 acts in nucleotide excision repair (NER) to eliminate pyrimidine dimers caused by UV light (Hwang et al., 1999) and in base excision repair (BER) caused by DNA hydrolysis and alkylation (Offer et al., 1999; Zhou et al., 2001) . Hence, by sequence-specific and nonsequencespecific DNA binding, p53 as the 'guardian of the genome' might regulate the cellular response to DNA damage in concert with the DNA repair machinery in order to select among multiple pathways toward DNA repair and apoptosis. Interestingly, while sequencespecific transactivation of p53 target genes is dependent on post-translational modification of p53 after DNA damage, all other activities could be displayed by a noninduced p53; for example, it may play a role in ribosomal biogenesis (Marechal et al., 1994) ; it may actively participate in BER (Offer et al., 1999) .
Various biochemical activities of p53 related to direct involvement in DNA repair are associated with nonsequence-specific binding to DNA (El-Deiry et al., 1992; Foord et al., 1993) : (a) p53 itself has the ability to recognize and interact with several forms of DNA such as single-stranded (ss) and double-stranded (ds) DNA ends, DNA with insertion-deletion lesion mismatches (Steinmeyer and Deppert, 1988; Kern et al., 1991; Lee et al., 1995) ; (b) p53 promotes the reannealing and strand transfer of short oligonucleotides (Bakalkin et al., 1994; Oberosler et al., 1993) ; (c) p53 checks the fidelity of homologous recombination processes by specific mismatch recognition (Dudenhoffer et al., 1998; Janz et al., 2002) ; and (d) wild-type (wt) p53 exhibits intrinsic 3 0 -5 0 exonuclease activity (Mummenbrauer et al., 1996; Huang, 1998) . Evidently, recombinant wtp53, by associated 3 0 -5 0 exonuclease, is able to preferentially remove mispaired nucleotides from 3 0 -of the DNA strand and enhance the accuracy of cellular and viral DNA synthesis. Indeed, it might act as an external proofreader for errors introduced by exonucleasedeficient cellular DNA polymerase a (Huang, 1998) , DNA polymerase a-primase (Melle and Nasheuer, 2002) and by retroviral murine leukemia virus (MLV) (Bakhanashvili, 2001a) or human immunodeficiency virus (HIV) reverse transcriptase (RT) (Bakhanashvili, 2001b) . This activity provides a molecular basis for p53 involvement in DNA replication machinery complexes where proofreading is necessary, thus contributing to the maintenance of genomic stability. Notably, the exonuclease activity of p53 must not be restricted to its noninduced state, but might also be exerted by a subclass of p53 after DNA damage when the protein is able to display its full range of possible biochemical activities . p53 was found in the nucleus, the cytoplasm or both compartments of the cell. p53 is retained in the cytoplasm during part of the normal cell cycle. The localization of p53 in the nucleus is essential for its normal function in growth inhibition or induction of apoptosis. Several studies have shown that wtp53 occurs in cytoplasm in a subset of human tumor cells such as breast cancers, colon cancers and neuroblastoma (Stenmark-Askmalm et al., 1994; Bosari et al., 1995; Moll et al., 1995) . Notably, besides structural mutation and the functional inactivation of wtp53, cytoplasmic sequestration of p53 in tumor cells (that do not have mutated p53) was suggested to be an important mechanism in abolishing p53 function and in tumorigenesis (Sun et al., 1992; Stenmark-Askmalm et al., 1994) . Interestingly, results from a number of studies have indicated that p53 plays a role in the control of protein synthesis. Cytoplasmic p53 functions include translational repression through binding to mRNAs or complexing with MDM-2, L5 ribosomal protein and/or 5.8S rRNA (Fontoura et al., 1992; Marechal et al., 1994) . The translational control by p53 is the first example indicating the functionality and significance of the presence of p53 in cytoplasm.
The role of p53-associated 3 0 -5 0 exonuclease in DNA repair machinery was observed in an in vitro model system with purified recombinant p53 and in whole cells (Mummenbrauer et al., 1996; Huang, 1998; Skalski et al., 2000; Bakhanashvili, 2001a; Ballal et al., 2002) . Since p53 is expressed constitutively in the cell and is distributed in the nucleus and cytoplasm, it was of interest to evaluate the subcellular location and extent of p53-associated 3 0 -5 0 exonuclease activity in cells. It was important to obtain p53 protein in the wt conformation and at a sufficient amount to examine its activity in an in vitro assay. Hence, in our study we took advantage of our recent observation that in MCF-7 human breast cancer cell line, even without exogenous DNA damage, wtp53 is mainly accumulated in the nucleus, whereas LCC2 cells (subline of MCF-7) maintain p53 predominantly within the cytoplasm (Lilling et al., 2002) . These properties make these cells particularly suitable as an experimental model system, since under p53 noninducible conditions, the absence of activated apoptotic pathways permits the analysis of p53-associated exonuclease activity in nuclear and cytoplasmic extracts, which requires relatively moderate levels of p53.
We found that the cytoplasmic fraction of LCC2 cells, expressing a high level of wtp53, exhibits 3 0 -5 0 exonuclease activity and displays biochemical properties characteristic of recombinant p53. Furthermore, depletion of p53 by anti-p53 monoclonal antibodies abolished the observed exonuclease activity. These data suggest that p53 in cytoplasm, in its noninduced state, is intrinsically functional.
Results

3
0 -5 0 exonuclease activity in nuclear and cytoplasmic extracts According to several studies, the onset of different p53-dependent activities correlates with the levels, localization and status of p53 in the cells. The fact that wtp53 normally is short-lived and is maintained at low levels in unstressed cells makes it difficult to use cellular extracts, either nuclear or cytoplasmic obtained from growing cells, as a suitable source for the analysis of p53-associated activities. However, nonstressed tumor cells express relatively high levels of wtp53. In our previous studies, both the immunohistochemistry and Western blot analyses showed that p53 was located in the nucleus of MCF-7 cells and in the cytoplasm of LCC2 cells (Lilling et al., 2002) . Hence, the experimental model system that we utilized included nonstressed human breast cancer cells MCF-7, LCC2 (both carrying wtp53), p53 in cytoplasm exhibits 3 0 -5 0 exonuclease activity G Lilling et al MDA-MB-231 (harboring mutant p53) and p53-null H1299 cells. We looked for a possible relationship between p53 and exonuclease activity. To accomplish this, the nuclear and cytoplasmic extracts of these cell lines were analysed for p53 expression by Western blot analysis and for exonuclease activity. Consistent with the published results, there is a difference in nuclear/ cytoplasmic distribution of p53 in these model cell lines (Lilling et al., 2002) : p53 is located mainly in the nuclear fraction of MCF-7 and MDA cells, in the cytoplasmic fraction of the LCC2 cells and is absent in H1299 cells ( Figure 1a ). These nuclear and cytoplasmic fractions were tested for the removal of the 3 0 -terminal mispair by exonuclease activity using dsDNA oligonucleotide containing A : A mispair at the 3 0 -terminus as substrate. The exonucleolytic activity was detected by excision of the 3 0 -terminal nucleotide, resulting in conversion of the 16-mer 5 0 -end labeled oligonucleotide to 15-mer, 14-mer, etc. with the correctly paired 3 0 -terminus ( Figure 1b) . Evidently, no exonuclease activity was detected in both compartments of H1299 cells. Interestingly, the results obtained revealed the existence of variations in constitutive exonuclease activity between nucleus and cytoplasm in association with p53. The nuclear extracts derived from all cell lines tested (LCC2 -expressing low levels of wtp53, MCF7 -expressing high levels of wtp53 or MDA -with mutant p53) exert low levels of exonuclease activity. Conversely, we noticed that cytoplasmic extracts display higher 3 0 -5 0 exonuclease activity than that induced by nuclear extracts. These results were reproduced four times with separate preparations of nuclear and cytoplasmic extracts. The formation of fragments was quantified by phosphorimaging. It is apparent that cytoplasmic extracts of Figure 1 Subcellular localization of p53 and 3 0 -5 0 exonuclease activity in cytoplasmic and nuclear protein extracts. (a) Analysis of p53 levels in MCF-7, H1299, MDA-MB-231 (MDA) and LCC2 cells by Western blotting. Cells were grown, harvested and nuclear and cytoplasmic fractions were obtained as described in the Materials and methods section. Equal protein samples (10 mg) from both nuclear (N) and cytoplasmic (C) fractions of these cells were subjected to SDS-PAGE and p53 protein expression was detected by the Do-1 anti-human p53 mAb. (b) The same samples were utilized for 3 0 -5 0 exonuclease activity. 3 0 -terminal nucleotide excision was examined using 3 0 -terminal A : A mismatch containing DNA/DNA template/primer (set II). The reaction was started by addition of cytoplasmic or nuclear fraction (3 mg). After 10-min incubation at 371C, 5 ml aliquots were withdrawn and analysed on 16% polyacrylamide gel, as described in the Materials and methods section. The position of the 16-mer primer is indicated by an arrow. (c) Controls for the subcellular fractionation. The distribution of the nuclear marker PCNA and the cytoplasmic marker b-tubulin was analyzed by immunoblotting to ascertain the purity of each fraction (to characterize nuclear and cytoplasmic fractions, respectively). Equal amounts (10 mg) of nuclear and cytoplasmic fractions of MCF-7 and LCC2 cells were tested for the appropriate antibodies p53 in cytoplasm exhibits 3 0 -5 0 exonuclease activity G Lilling et al LCC2 cells, carrying high levels of wtp53, exhibit an enhanced exonuclease activity (57%) in comparison to those expressing either a lower level of p53 in MCF-7 (12%) or the mutant p53 in MDA cells. It should be noted that the fractionation procedure was performed in parallel with all cell lines used. The fact that MCF-7 cells, in which p53 was expressed in the nucleus, had low levels of exonuclease activity in cytoplasm indicates the likelihood that the observed exonuclease activity in LCC2 cells is directly linked to cytoplasmic p53 (detected by immunohistochemistry - Lilling et al. (2002) -and Western blot analysis - Figure 1a ). Nevertheless, it was important to rule out the possibility that p53 in cytoplasm may be due to leakage of nuclear proteins. Consequently, the completeness of the subcellular fractionation was determined by monitoring the distribution of known nuclear and cytoplasmic marker proteins in MCF-7 and LCC2 cells. As is evident from Figure 1c , b-tubulin, a commonly used cytoplasmic marker, was found exclusively in the cytoplasmic fraction, whereas PCNA was predominantly nuclear. Hence, specific distribution of markers for cytoplasm and nucleus, respectively, indicates that the subcellular fractionation procedure was appropriate. Taken together, the experiments revealed an interesting observation correlating the extent of exonuclease activity with the level and status of p53 in cytoplasm but not in the nucleus.
The observed exonuclease activity from the cytoplasmic fraction of LCC2 cells removes the 3 0 -terminal nucleotide as a function of time (increasing incubation time resulted in increased abundance of the shorter species) (Figure 2a ) and in a dose-dependent manner (exonuclease activity was proportional to the concentration of the cytoplasmic extract) (Figure 2b ).
DNA polymerase g in mitochondria possesses 3 0 -5 0 exonuclease activity (Gray and Wong, 1992; Olson and Kaguni, 1992) . To exclude the possibility that observed exonuclease activity in cytoplasm stems from mitochondrial DNA polymerase g, highly enriched mitochondrial fractions (M) from LCC2 cells (comprising a very small portion of p53) along with mitochondria-free cytoplasmic (CMF) fractions (comprising a great portion of p53) ( Figure 3a ) were tested for exonuclease activity. As depicted from Figure 3b , the exonuclease activity in the mitochondria-free cytoplasmic fraction was significantly higher than in the mitochondrial extract. These results suggest that there is a positive correlation between the p53 accumulation in the mitochondria-free cytoplasmic fraction and 3 0 -5 h exonuclease activity. Apparently, mitochondrial DNA polymerase g is not responsible for the observed exonuclease activity in the cytoplasmic fraction.
To further investigate the possible correlation between p53 and exonuclease activity, it was essential to confirm that the detected exonuclease activity in the cytoplasmic fraction of LCC2 cells is attributed to p53. We immunodepleted the p53 from the cytoplasmic extracts of LCC2 cells (expressing high levels of p53 and exonuclease activity) to examine whether it would abolish this function of the protein. 0 -terminal mispair. Thus, the inhibition of excision reaction was most probably caused by abolishing the p53 associated exonuclease activity.
Collectively, the data indicate a possible link between the presence of p53 in the cytoplasmic fraction and 3 0 -5 0 exonuclease activity. Recent studies revealed that recombinant wtp53 removes 3 0 -terminal nucleotides from various nucleic acid substrates. The spectrum of substrates utilized by p53 includes ssDNA, DNA/DNA and RNA/DNA substrates (Huang, 1998; Skalski et al., 2000; Bakhanashvili, 2001b) . We attempted to elucidate potential substrates for exonuclease detected in the cytoplasmic fraction of LCC2 cells. To test this, the 32 P-labeled 16-mer primer alone or hybridized to either complementary DNA or RNA were used as ssDNA, dsDNA and RNA/ DNA substrates, respectively. The results obtained demonstrate that 3 0 -5 0 exonuclease activity is able to hydrolyze dNMPs from the 3 0 -terminus of all three substrates ( Figure 5 ). However, the cleavage of the ssDNA is substantially higher than that of the DNA/ DNA or RNA/DNA template-primers, thus indicating that the cytoplasmic exonuclease, similar to recombinant wtp53, preferentially recognized the ss character of these substrates. It should be noted that the exonuclease activity is not associated with DNA polymerase, since oligonucleotide bands greater than 16 nucleotides in length are not detected even though dNTPs are included in the reactions (data not shown). The observed substrate specificity indicates that the exonuclease could function in several DNA repair pathways during DNAand RNA-dependent DNA polymerization reactions.
The 3 0 -terminal base excision capacity of 3 0 -5 0 exonuclease in cytoplasmic extracts from LCC2 cells was further analysed under nonpolymerization conditions with four DNA/DNA (set II) or RNA/DNA (set I) template-primers containing either an incorrect A : A, A : C, A : G or correct A : T base pair at 3 0 -termini. The ability of 3 0 -5 0 exonuclease from the cytoplasmic fraction of LCC2 cells to remove 3 0 -terminal mispairs from DNA/DNA and RNA/DNA substrates is illustrated in Figure 6a . It is apparent that under nonpolymerization conditions, the exonuclease excises the 3 0 -terminal nucleotide from all primers tested, although there are variations in the degradation pattern of the different mispairs. The exonuclease exhibits a preference for mismatched rather than matched bases with both substrates. Indeed, with the DNA/DNA template-primer, removal of the 3 0 -terminal mismatched A : A or A : G nucleotide (19 and 43%, respectively) is more efficient than that of a complementary terminal base pair A : T (9%), indicating a specificity toward the degradation of a mispaired primer end. The trend in the order of a 3 0 -terminal mispair excision opposite a template A residue with both DNA/DNA and RNA/ DNA template-primers is pur.pur>pur.pyr. The mispair excision specificity was further assessed with separate four template-primer substrates of DNA/ DNA (set III) or RNA/DNA (set IV), containing 3 0 -terminal mispaired nucleotides opposite a template G residue. As shown in Figure 6b , exonuclease in the cytoplasmic fraction of LCC2 cells is most reactive again with purine-purine G : A and G : G mispairs (17 and 12%, respectively). The specificity of mispair excision with both substrates is G : A>G : G>G : T. Evidently, there is a difference in mispair excision efficiency between the two sets of template-primers utilized; namely, the mispairs opposite target A ( Figure 6a ) were excised more efficiently compared to those opposite target G (Figure 6b ). This dissimilarity probably stems from (i) the nature of the mispair and/or (ii) the difference in nearest neighbors from a template target site (GA-purines in Figure 6a and CT-pyrimidines in Figure 6b) . Notably, the same type of preformed mismatches were chosen in the same sequence context that was previously employed with recombinant wtp53 with both DNA/DNA and RNA/ DNA substrates (Bakhanashvili, 2001a,b) . The mispair 0 -5 0 exonuclease activity in mitochondrial and cytoplasmic extracts of LCC2 cells. (a) Analysis of p53 levels by Western blotting was performed with protein samples from mitochondria-enriched fraction (M), mitochondriafree cytoplasmic fraction (CMF) and total cytoplasmic fraction (C) of LCC2 cells. Identical protein samples (10 mg each) of the subcellular fractions were subjected to SDS-PAGE and the p53 protein level was detected as described in Figure 1 . (b) The same samples were utilized for 3 0 -5 0 exonuclease activity. 3 0 -terminal nucleotide excision by exonuclease was examined by incubation with each subcellular fraction (1 mg) as described in Figure 1 . 3 0 -terminal nucleotide excision was examined using 3 0 -terminal A : A mismatch containing DNA/DNA template/primer (set II). The position of the 16-mer primer is indicated by an arrow p53 in cytoplasm exhibits 3 0 -5 0 exonuclease activity G Lilling et al excision pattern detected in the current study is compatible with similar results obtained previously with recombinant wtp53. Thus, the data suggest that the 3 0 -5 0 exonuclease from the cytoplasmic fraction of LCC2 cells is active when first binding to a 3 0 -terminus and prefers transversion mutations over transition mutations. The preference for excision of mispaired 3 0 -termini suggests a role in exonucleolytic proofreading, generating the correctly base-paired 3 0 -termini necessary for continued DNA synthesis.
Functional interaction between 3
0 -5 0 exonuclease from the cytoplasmic fraction of LCC2 cells and exonucleasedeficient MLV RT For DNA polymerases that lack an intrinsic proofreading activity, it is possible that excision could be performed by a separate exonuclease. To determine whether exonuclease in the cytoplasmic fraction could reduce the replication errors induced by exonucleasedeficient polymerase, the fidelity of DNA synthesis by MLV RT (lacking intrinsic exonuclease activity and representing a relatively low-fidelity DNA polymerase) was evaluated in the presence of the cytoplasmic extract of LCC2 cells. We used an in vitro gel fidelity assay that proved to be useful to identify the proofreading stimulatory factors. This system allows the simultaneous detection of both degradation (exonucleolysis) and extension (polymerization) to investigate the contribution of exonuclease activity in correcting MLV RT errors during the DNA synthesis. In general, proofreading 3 0 -5 0 exonuclease activity enhances in less stable DNA regions, leading to a reduction in base substitution error frequencies in AT-vs GC-rich sequences (Wang et al., 2002) . Hence, sequences were chosen to provide an AT-environment from a template target site to maximize proofreading. To assess the cooperation of the exonuclease from the cytoplasmic fraction of LCC2 cells and MLV RT, we carried out two reactions indicative of the fidelity of DNA synthesis: the misinsertion and mispair extension, during both DNA-dependent DNA polymerization (DDDP) and RNA-dependent DNA polymerization (RDDP) reactions.
(a) The insertional fidelity of MLV RT was examined with both substrates using running-start templateprimer. The reactions were performed at a fixed concentration of 0.5 mm of dATP, allowing the extension of the 16-mer primer. The results of the primer extension assays show that MLV RT displays misinsertion activity with both substrates, incorporating dATP opposite the template G at site 10 of template DNA ( extension products longer than 19-mer suggests that the creation of first mismatch (A : G) was followed by elongation. This reflects the ability of the enzyme not only to misinsert a wrong dATP (mutator phenotype), but also to extend the newly formed mispair. Interestingly, the misincorporation of dATP was reduced with both template-primers in the presence of cytoplasmic extract of LCC2 cells (Figure 7, lanes 2 and 4) . Apparently, the 3 0 -5 0 exonuclease activity in cytoplasmic fraction affected the polymerase selectivity for base substitution errors during both DDDP and RDDP reactions; it substantially reduced the number of mismatched nucleotides incorporated into DNA.
(b) The efficient extension of mismatched 3 0 -termini of DNA in concert with the ability to introduce mispairs is a major factor affecting the low accuracy of DNA synthesis exhibited by different DNA polymerases (Perrino et al., 1989; Hizi, 1992a, 1993) . Therefore, the 3 0 -5 0 exonuclease from the cytoplasmic fraction of LCC2 cells was further assessed for its influence on the mispair extension ability of MLV RT. The slow mismatch extension capacity of the enzyme could allow a separate exonuclease to compete for mismatched primer termini. Hence, the mispair extension capacity of MLV RT was evaluated in the presence of the cytoplasmic fraction of LCC2 cells by analysing the extension of DNA/DNA and RNA/DNA template-primers containing A : A and A : C mispairs (substrates that were efficiently extended by MLV RT) (Bakhanashvili and Hizi, 1992a ) and the next complementary nucleotide dATP (as the only dNTP present). Under the assay conditions, the polymerase displayed a characteristic mispair extension profile with both substrates. Indeed, MLV RT elongates the A : A and A : C mispairs, accumulating the correct A : T 17-and 18-residue primers (Figure 8 , lanes 1, 2, 5 and 6). However, the mispair extension pattern was different in the presence of the cytoplasmic fraction of LCC2 cells; namely, a reduction in elongation of the primer was observed. Indeed, hydrolysis of the 3 0 -terminal nucleotide resulted in decreased intensities of the 18-mer and 17-mer bands, concomitant with the appearance of (15-mer, 14-mer and etc.) products resulting from 3 0 -5 0 exonuclease activity (Figure 8 , lanes 3, 4, 7 and 8).
Hence, the data indicate that MLV RT with both template-primers displays a lower capacity of mispair extension in the presence of the cytoplasmic fraction of LCC2 cells expressing wtp53. These proofreading results imply a functional cooperation of polymerization (by MLV RT) and excision (by exonuclease from the cytoplasmic fraction) activities, which act in a coordinated manner during DNA synthesis at the templateprimer site to achieve a high accuracy of DNA synthesis. These findings suggest that the exonuclease in cytoplasm might fulfill a proofreading function; namely, it can correct replication errors made by exonuclease-deficient DNA polymerase and its biochemical properties are fully consistent with those of recombinant wtp53.
Discussion
Current studies revealed two interesting observations: (a) p53 in the cytoplasmic fraction of nonstressed cells is functional; it exerts 3 0 -5 0 exonuclease activity and (b) p53 in nuclear extracts displays a relatively low level of 3 0 -5 0 exonuclease activity in comparison to cytoplasmic extracts.
Using an in vitro model system, we found that the cytoplasmic extracts of LCC2 cells expressing wtp53 Notably, the purity of cellular fractionation was determined by monitoring the distribution of proteins that have specific cellular localization ( Figure 1c) . Thus, our results appear to be an accurate reflection of the 
presence of p53 in the cytoplasm. Collectively, the data indicate that wtp53 in cytoplasm, in its noninduced state, displays intrinsic 3 0 -5 0 exonuclease activity. Interestingly, 3 0 -5 0 exonuclease activity and sequencespecific DNA binding are mediated by the p53 core domain. Evidently, these two activities are mutually exclusive activities; they are subject to different and opposing regulatory mechanisms. It was suggested that p53 loses its exonuclease activity when the sequencespecific DNA binding of p53 becomes activated (Janus et al., 1999) . Importantly, cytoplasmic p53 fails to bind to its specific DNA target (Ostermeyer et al., 1996) . This property is consistent with our results that p53 in cytoplasm may act as exonuclease. It is noteworthy, that in nonstressed cells p53 exists in a transcriptional inert state. In this form, p53 may participate in DNA repair pathways. The fact that purified recombinant p53 as well as p53 in cytoplasmic extract exerts 3 0 -5 0 exonuclease activity suggests that this function probably does not depend on p53 transactivation activity. The biochemical difference between the p53 in nuclear and cytoplasmic compartments raises questions as to whether nuclear p53 loses exonuclease function of cytoplasmic p53 or acquires an additional function (e.g. efficient sequence-specific DNA binding and transactivation). Our fractionation procedure consists of nuclear protein extraction in the presence of 420 mm NaCl (see the Materials and methods section). It was demonstrated that increased ionic strength destabilizes and dissociates binding of p53 to DNA (Butcher et al., 1994) . Hence, the possibility that p53-associated 3 0 -5 0 exonuclease activity is easier detected in cytoplasm (when it is not bound to DNA) than in the nucleus is highly unlikely. There is a possibility that the difference stems from one of the following mechanisms: (i) intramolecular (e.g. post-translational modification, conformational) or (ii) intermolecular (binding to another protein). (i) Post-translational modifications (e.g. phosphorylation, acetylation) play a critical role in the outcome of protein activation (Meek, 1998) . Hence, it will be interesting to examine whether any of the posttranslational modifications are involved in regulating the ability of p53 to serve as an exonuclease in the nucleus and in the cytoplasm. wt p53 can exist in two different conformations; mutant and wt. Changes in the conformational status of endogenous p53 have been reported in cultured cells, and suggested that this may be an important process in its functional activity (Milner and Watson, 1990; Sabapathy et al., 1997) . Recently, it was demonstrated that nuclear translocation of p53 can result in a change in the conformation from mutant (in cytoplasm) to wild type (in nucleus) (Gaitonde et al., 2000) . Hence, it is conceivable that the alteration of p53 protein conformation is responsible for the low level of exonuclease activity in the nucleus.
(ii) The interaction of p53 with other proteins has key roles in its various cellular activities. There is a possibility that the selectivity of the functions can be provided by its association with different DNA repair proteins.
Furthermore, recent studies demonstrate that p53 has the capacity for simultaneous binding of both F-actin and DNA containing insertion-deletion mismatches (Okorokov et al., 2002) . It is conceivable to speculate that in the nucleus, upon interaction with the F-actin and DNA repair proteins, p53 becomes modified and is then liberated to exert various functions. It is noteworthy that changes in the conformation of p53 may be mediated also by association with other proteins. In the nucleus, cells developed multiple DNA repair pathways to protect themselves from different types of endogenous and exogenous DNA damage. p53-dependent BER repair occurs in vivo and does not depend on p53 transactivation activity (Offer et al., 1999) . There is a possibility that in non-stressed cells, in an endogenous DNA damage status, p53 in the nucleus is more competent for the p53-associated BER pathway than for 3 0 -5 0 exonuclease activity. Importantly, human p53, which is induced by high doses of g irradiation, exhibits approximately 10-fold more exonuclease activity, thus indicating that this biochemical function of p53 may be subject to stimulation by exogenous stimuli (Huang, 1998) . Hence, it is of interest to elucidate 3 0 -5 0 exonuclease activity in the nucleus and cytoplasm of the cells with activated p53 induced by drug treatments (in the absence of DNA damage) or following UV irradiation (in the presence of DNA damage). The studies are presently under way. In this regard, it is attractive to speculate that the induction allows p53 to function in several ways: as a regulator of transcription, as a facilitator of BER and as an exonucleolytic proofreader. Moreover, there is a possibility that both transcription-independent pathways act in synergy, thereby amplifying the potency of involvement of p53 in DNA repair. There are several reports describing exonucleases not associated with DNA polymerases. The exonucleases detected were purified and characterized from whole cells or from nuclear extracts of human and animal cells (Vazquez-Padua et al., 1990; Harrington et al., 1993; Perrino et al., 1994; Hoss et al., 1999) . However, only one has been identified in the cytoplasm of human H9 cells (Skalski et al., 1995) . The exonuclease activity detected in the cytoplasm of LCC2 cells and the cytosolic exonuclease from H9 cells exhibit some similar properties: (1) divalent metal requirement and salt profile (data not shown) and (2) substrate specificity; namely, both exonucleases are reactive with ssDNA, DNA/DNA and RNA/DNA substrates. However, there is a difference in mispair excision specificity. The cytosolic exonuclease from H9 cells was most reactive with the purine-pyrimidine mispair (e.g. G:T), while exonuclease, either from the cytoplasmic extract of LCC2 cells or associated with recombinant p53 (Bakhanashvili, 2001b) , prefers purine-purine mispairs (e.g. A:A, A:G, G:G, G:A) over the purine-pyrimidine mispairs (e.g. A:C, G:T). Thus, the behavior of the exonuclease from the cytoplasmic fraction of LCC2 cells on mismatch-terminated DNA indicates that probably it is a previously uncharacterized exonuclease activity.
Different functional subclasses of p53 exist within the same cell that may perform different functions according to their subcellular localization. p53 is retained in the p53 in cytoplasm exhibits 3 0 -5 0 exonuclease activity G Lilling et al cytoplasm during part of the normal cell cycle as well as in certain tumor cells. It was suggested that p53 might be associated with cytoplasmic ribosomes and that the p53-5.8S rRNA complex might be involved in ribosome biogenesis and/or translational regulation in the cell (Fontoura et al., 1992) . These data, taken together with our results that p53 in the cytoplasm may serve as an exonucleolytic proofreader, indicate that noninduced p53 is functional and is able to elicit a spectrum of different biological effective pathways in the cytoplasm as well as in the nucleus. It is remarkable that although p53 displays various activities, not all functions are active simultaneously. Hence, these observations raise the question as to whether p53 may serve a dual purpose in cytoplasm, i.e. translation control and exonucleolytic proofreading, independently or simultaneously.
A particular 3 0 -5 0 exonuclease might have more than one function in the cell (Shevelev and Hubscher, 2002) . The data obtained raise questions about the possible functional role of p53-associated 3 0 -5 0 exonuclease activity in the cytoplasm of normal and tumor cells. In unstressed cells, this activity of p53 may be viewed as a 'housekeeping' function. Eukaryotic RNA species require exonucleolytic activities for processing and for their turnover, which may have an impact on the extent and regulation of translation (Wickens et al., 1997) . Thus, there is a possibility that p53 by associated exonuclease activity may be involved in the efficiency and fidelity of protein synthesis. The fact that the exonuclease function of p53 may be subject to stimulation by exogenous stimuli raises the possibility that the induction allows p53 to function in two ways: (a) as an exonuclease; p53 could provide the cell with a mechanism for recognizing and destroying ssDNA of pathogen and (b) as a proofreader for DNA polymerases lacking inherent exonuclease. Viruses use cell proteins for multiple purposes during their intracellular replication cycles. p53 protein by its ability to excise mispaired bases from DNA/DNA and RNA/DNA templateprimers may be relevant to the fidelity of DNA replication of viruses in cytoplasm, e.g. hepatitis B virus (HBV) or HIV. In our previous studies, we noticed an enhancement of the fidelity of HIV-1 RT by recombinant p53 (Bakhanashvili, 2001b) . Notably, HIV infections seem to increase the intracellular level of p53 (Genini et al., 2001) . In view of these observations, it seems reasonable to hypothesize that p53 in the cytoplasm may provide a proofreading function for HIV-1 RT (manuscript in preparation). The observations presented here open new avenues for investigating the role of p53-associated exonuclease in cytoplasm.
Materials and methods
Cell lines and culture medium
The MCF-7 and MDA-MB-231 human breast cancer cell lines were grown in DMEM+10% fetal calf serum (FCS). The LCC2 cells (subclone derived from MCF-7) were grown in DMEM lacking phenol red+10% charcoal stripped FCS (CSS), H1299 cell line was grown in the presence of RPMI 1640+10% FCS. All lines were maintained in a humidified 95% air, 5% CO 2 atmosphere.
Subcellular fractionation and Western blotting
Cells were harvested by trypsin-EDTA, washed by PBS and fractionated according to Andrews and Faller (1991) . Incubation was performed in the presence of ice-cold hypotonic buffer (10 mm HEPES-KOH pH 7.9, 1.5 mm MgCl 2 , 10 mm KCl, O.5 mm DTT, 0.2 mm PMSF) and 0.6% of NP-40 for 15 min followed by centrifugation at 15 000 g for 2 min at 41C, and the supernatant was the cytoplasmic fraction. The pellet was washed once with the hypotonic buffer. Nuclear proteins were extracted by incubation on a rotating platform for 20 min in hypertonic buffer (20 mm HEPES-KOH, pH 7.9. 25% glycerol, 420 mm NaCl, 1.5 mm MgCl 2 , 0.2 mm EDTA, 0.5 mm DTT, 0.2 mm PMSF) followed by centrifugation at 15 000 g for 15 min at 41C and the supernatant was the nuclear fraction. Protein concentration from both fractions was determined using the Bradford assay (Bio-Rad Lab., Hercules, CA, USA). Identical protein amounts of both fractions were subjected to PAGE. The p53 protein was detected by the Do-1, anti-p53 monoclonal antibody (mAb) (ascitic fluid diluted in PBST (a generous gift from Prof. V. Rotter, Weizmann Inst., Israel) 1:300), followed by HRP-conjugated goat-anti-mouse Ab (Jackson Lab., West Grove, PA, USA). Visualization of the p53 expression was performed by an EzECL kit (Biological Industries, Bet Haemek, Israel) according to the protocol. b-tubulin was detected by anti-human b-tubulin mAb and PCNA by anti-human PCNA mAb (purchased from Zymed Lab. Inc. So, San Francisco, CA, USA).
Immunoprecipitation for p53 protein The cytoplasmic fraction of LCC2 cells was incubated in the presence of Do-1, anti-human p53 monoclonal antibody (mAb) or with antihorse IgG (H+L) mAb with 360 o rotation at 41C, followed by incubation in the presence of anti-mouse IgG conjugated to agarose (Sigma). The supernatants were collected after removal by centrifugation at 14 000 g for 5 min at 251C and examined for p53 expression by Western Blotting and exonuclease reactions.
Preparation of mitochondrial fraction Mitochondria were prepared as described (Bogenhagen and Clayton, 1974) . Briefly, cells washed in TD buffer were centrifuged (300g at 41C) and resuspended in MgRSB buffer (1.5 mm MgCl 2 , 10 mm NaCl, 10 mM Tris, pH 7.5) and incubated for 10 min. Swollen cells were disrupted in a glass Dounce homogenizer to yield approximately 95% of free nuclei. Mitochondria was pelleted from the washed homogenate, resuspended in manitol-sucrose buffer and layered over a 1-2 m discontinuous sucrose gradient and spun at 41C for 30 min at 110 000 r.p.m. The mitochondria (M) were collected from the 1.0-1.5 sucrose interphase. The supernatant was referred to as the mitochondria-free cytoplasmic fraction (CMF).
Template-primers Four template-primer substrates were used for the excision and polymerization reactions. The first (set I), ribosomal RNA (rRNA), as a native substrate (a mixture of 16S and 23S Eschericia coli rRNA), was primed with 16-mer oligonucleotide primer, which hybridizes to the nucleotides at positions 2112-2127 of the 16S rRNA. Four versions of primers were synthesized separately. They are p53 in cytoplasm exhibits 3 0 -5 0 exonuclease activity G Lilling et al identical except for the 3 0 -terminal nucleotide (N), which is either A, C, G or T. The sequence of these oligonucleotide primers is 5 0 -ATTTCACATCTGACTN-3 0 and (a). The second (set II) is an (N) 30 synthetic oligonucleotide DNA template with a sequence derived from nucleotides 2100-2129 of E. coli 16S rRNA (5 0 -AGGCGGTTTGTTAAGT-CAGATGTGAAATCC-3 0 ). This DNA is primed with an (N) 16 oligonucleotide (utilized with rRNA template) that hybridizes to the nucleotides at positions 13-28 of the template DNA. Consequently, by hybridizing the primer oligonucleotides to the rRNA template at position 2112 or DNA template at position 13, the A : A, A : C, A : G mispairs or the A:T correctly paired terminus were produced. The third (set III) is the same (N) 30 template DNA primed with an (N) 16 The end-labeled primers were annealed to the template RNA or DNA as described Hizi, 1992b, 1993) .
Exonuclease assays The 3 0 -5 0 exonucleolytic activity was measured as the removal of 3 0 -terminal nucleotides (correct or incorrect) from the 5 0 -[g-32 P] end-labeled oligonucleotide, determined by the increase in mobility during the gel electrophoresis. The incubation mixture (12.5 ml) contained 50 mm Tris-HCl (pH 7.5), 5 mm MgCl 2 , 1 mm DTT, 0.1 mg/ ml BSA and 5 0 -end-labeled various substrates. The reaction was started by the addition of 3 mg of nuclear or cytoplasmic extract. The variables, including reaction time and amounts of the extracts, are given in the legends to the figures. Assays were carried out at 371C. At appropriate time points the reactions were stopped by the addition of an equal volume of formamide gel loading buffer, followed by incubation at 901C for 3 min. The reaction products were resolved by electrophoresis through a 16% polyacrylamide sequencing gel (PAGE). Exonuclease activity, measured as the reduction in size of labeled oligonucleotides, was detected by autoradiography. The excision products were quantified by densitometric scanning of gel autoradiographs.
Exonuclease/polymerase coupled assays To evaluate the interaction between exonuclease in the cytoplasmic fraction of the cells and MLV RT, the same template-primers (sets I and II) used for the exonuclease activity were utilized as substrates. When present, MLV RT was at 1.5 U/ml. For site-specific nucleotide misinsertion, a correctly paired template-primer substrates was used to analyse the dATP misincorporation opposite the G residues at position 10 of the DNA template or at position 2009 of the RNA template. For the mispair extension, elongation of the 5 0 -end-labeled template-primers was examined in the presence of dATP as the only dNTP present. The dNTPs used were of the highest purity available (Pharmacia Biotech.) with no detectable traces of contamination by other dNTPs. The reaction products were analysed by electrophoresis through 16% PAGE as described above. Degradation or extension of the 5 0 -end-labeled primers was detected by autoradiography.
